Loading clinical trials...
Loading clinical trials...
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial to Assess the Safety and Efficacy of 5% Monolaurin Vaginal Gel Administered Intravaginally for the Treatment of Bacterial Vaginosis
Conditions
Interventions
5% Monolaurin Vaginal Gel
Placebo
Locations
3
United States
University of Iowa - Vaccine Research and Education Unit
Iowa City, Iowa, United States
Duke Human Vaccine Institute - Duke Clinical Vaccine Unit
Durham, North Carolina, United States
Cincinnati Children's Hospital Medical Center - Infectious Diseases
Cincinnati, Ohio, United States
Start Date
April 14, 2016
Primary Completion Date
December 11, 2017
Completion Date
December 11, 2017
Last Updated
December 28, 2018
NCT07394777
NCT06472765
NCT06469164
NCT06470906
NCT06123299
NCT02432404
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions